Who
Francoise de Craecker
Director
Company insider
Files Form 4 as: Director, X4 Pharmaceuticals.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 14 Oct 2021
- Last trade
- 1 Jan 2026
- Last filed
- 5 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jan 2026filed 5 Jan 2026 | XFOR X4 Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | XFOR X4 Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 9 Jun 2025filed 10 Jun 2025 | XFOR X4 PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 10 Jun 2024filed 11 Jun 2024 | XFOR X4 PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 13 Jun 2023filed 14 Jun 2023 | XFOR X4 PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 6 Jun 2022filed 27 Jun 2022 | XFOR X4 PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —6,667 at $0.00 | filing |
| 14 Oct 2021filed 18 Oct 2021 | XFOR X4 Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,250 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.